Pharsight

Drugs that contain Procainamide Hydrochloride

1. Procanbid patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5656296 KING PHARMS Dual control sustained release drug delivery systems and methods for preparing same
Aug, 2014

(9 years ago)

Market Authorisation Date: 31 January, 1996

Treatment: NA

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage

PROCANBID family patents

Family Patents